ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
Dow Jones
42,992.21
-0.77%
US Dollar vs MXN
20.39303
0.34%
Brent Oil
73.805
0.24%
Bitcoin
93,671.26
0.16%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Europa
  5. EU

  6. Ackermans and Van Haaren NV (ACKB) Cotización

Ackermans and Van Haaren NV

Ackermans and Van Haaren NV (ACKB)

EU
190.00
0.90
(0.48%)
Cerrado 29 Diciembre 10:30AM
Delayed by 15 minutes

Mejore su cartera: debates en tiempo real e ideas comerciales prácticas.

Premium

Estadísticas y detalles clave

Último Precio
190.00
Postura de Compra
189.40
Postura de Venta
190.20
Volume Operado de la Acción
21,678
189.00 Rango del Día 190.40
152.90 Rango de 52 semanas 193.70
Capitalización de Mercado [m]
6.364B
Precio Anterior
189.10
Precio de Apertura
190.00
Hora
5
@
190
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
27,350
Acciones en circulación
33,497,000
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
15.94
Beneficio por acción (BPA)
11.92
turnover
4.99B
Beneficio neto
399.19M

Acerca de Ackermans and Van Haaren NV

Sector
Heavy Construction, Nec
Industria
Heavy Construction, Nec
Sitio web
www.avh.be
Sede
Antwerp, Antwerp, Bel
Fundado
1880
Ackermans and Van Haaren NV is listed in the Heavy Construction sector of the Euronext with ticker ACKB. The last closing price for Ackermans and Van Haaren... was 189.10 €. Over the last year, Ackermans and Van Haaren... shares have traded in a share price range of 152.90 € to 193.70 €.

Ackermans and Van Haaren... currently has 33,497,000 shares in issue. The market capitalisation of Ackermans and Van Haaren... is 6.33 € billion. Ackermans and Van Haaren... has a price to earnings ratio (PE ratio) of 15.94.

ACKB Últimas noticias

Más noticias

Ackermans & van Haaren Trading Update T3 2024 - AvH en bonne voie de réaliser un bénéfice bien supérieur à 400 millions d’euros.

Ackermans & van Haaren Trading Update T3 2024 - AvH en bonne voie de réaliser un bénéfice bien supérieur à 400 millions d’euros. Cher actionnaire, Monsieur, Madame, veuillez trouver ci-joint...

22 Noviembre 2024
UK Regulatory

Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros

Ackermans & van Haaren Trading Update Q3 2024 - AvH is on track towards a net profit well above 400 million euros Dear shareholder, Dear Madam, Dear Sir, please find attached our press...

22 Noviembre 2024
UK Regulatory

Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co

Ackermans & van Haaren and the Delen family confirm their long-term partnership with updated shareholder arrangements in respect of Delen Private Bank and Bank J. Van Breda & Co Dear...

21 Noviembre 2024
UK Regulatory

Ackermans & van Haaren et la famille Delen confirment leur partenariat à long terme en actualisant les conventions d'actionnaires concernant Delen Private Bank et Bank J.Van Breda & Co

Ackermans & van Haaren et la famille Delen confirment leur partenariat à long terme en actualisant les conventions d'actionnaires concernant Delen Private Bank et Bank J.Van Breda &...

21 Noviembre 2024
UK Regulatory

Ackermans & van Haaren investit 5 millions d’euros supplémentaires dans Biotalys

Ackermans & van Haaren investit 5 millions d’euros supplémentaires dans Biotalys Cher actionnaire, Monsieur, Madame, veuillez trouver ci-joint notre communiqué. Meilleures salutations...

14 Octubre 2024
UK Regulatory

Ackermans & van Haaren invests an additional 5 million euros in Biotalys

Ackermans & van Haaren invests an additional 5 million euros in Biotalys Dear shareholder, Dear Madam, Dear Sir, please find attached our press release. Best regards Ackermans & van Haaren...

14 Octubre 2024
UK Regulatory

Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%)

Ackermans & van Haaren: Outstanding results in core participations result in a strong increase of AvH's net profit for 1H2024 to EUR 200 million (+17%) Dear shareholder, Dear Madam, Dear...

30 Agosto 2024
UK Regulatory

Ackermans & van Haaren : Des résultats exceptionnels dans les participations principales entraînent une forte augmentation du bénéfice net qui atteint € 200 millions (+17%)

Ackermans & van Haaren : Des résultats exceptionnels dans les participations principales entraînent une forte augmentation du bénéfice net qui atteint € 200 millions (+17%) Cher actionnaire...

30 Agosto 2024
UK Regulatory

Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company

Ackermans & van Haaren leads EUR 60 million Series B Financing Round for Confo Therapeutics, a Belgian clinical-stage biopharmaceutical company Dear shareholder, Dear Madam, Dear Sir, please...

26 Julio 2024
UK Regulatory

Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics, une société biopharmaceutique belge

Ackermans & van Haaren mène une levée de fonds de série B de 60 millions d'euros pour Confo Therapeutics, une société biopharmaceutique belge Cher actionnaire, Monsieur, Madame, veuillez...

26 Julio 2024
UK Regulatory
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
142.15053763441186190.4184.525072187.08370182DE
44.32.3155627356185.7191.4184.528271188.40469307DE
124.22.26049515608185.8192.2178.927350187.43029207DE
2627.416.8511685117162.6193.716127610181.70370681DE
5231.519.8738170347158.5193.7152.926582171.49589897DE
15625.215.2912621359164.8193.7126.624864159.75866165DE
26048.233.9915373766141.8193.742.0425410148.31204629DE

ACKB - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Ackermans and Van Haaren...?
El precio actual de las acciones de Ackermans and Van Haaren... es 190.00 €
¿Cuántas acciones de Ackermans and Van Haaren... están en circulación?
Ackermans and Van Haaren... tiene 33,497,000 acciones en circulación
¿Cuál es la capitalización de mercado de Ackermans and Van Haaren...?
La capitalización de mercado de Ackermans and Van Haaren... es EUR 6.33B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Ackermans and Van Haaren...?
Ackermans and Van Haaren... ha negociado en un rango de 152.90 € a 193.70 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Ackermans and Van Haaren...?
El ratio precio/beneficio de Ackermans and Van Haaren... es 15.94
¿Cuál es el ratio de efectivo a ventas de Ackermans and Van Haaren...?
El ratio de efectivo a ventas de Ackermans and Van Haaren... es 1.28
¿Cuál es la moneda de reporte de Ackermans and Van Haaren...?
Ackermans and Van Haaren... presenta sus resultados financieros en EUR
¿Cuál es el último ingresos anual de Ackermans and Van Haaren...?
El último ingresos anual de Ackermans and Van Haaren... es EUR 4.99B
¿Cuál es el último beneficio anual de Ackermans and Van Haaren...?
El último beneficio anual de Ackermans and Van Haaren... es EUR 399.19M
¿Cuál es la dirección registrada de Ackermans and Van Haaren...?
La dirección registrada de Ackermans and Van Haaren... es BEGIJNENVEST 113, ANTWERP, ANTWERP, 2000
¿Cuál es la dirección del sitio web de Ackermans and Van Haaren...?
La dirección del sitio web de Ackermans and Van Haaren... es www.avh.be
¿En qué sector industrial opera Ackermans and Van Haaren...?
Ackermans and Van Haaren... opera en el sector HEAVY CONSTRUCTION, NEC

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
ALEMSEuropean Medical Solutions
6.70 €
(37,122.22%)
40
CFNCofina SGPS SA
15.95 €
(2,146.48%)
2.17k
DMSBSDiagnostic Medical Systems
0.003 €
(50.00%)
52k
ALTROTronic s Microsystems
5.00 €
(48.81%)
8
SEQUASequana medical NV
3.87 €
(40.22%)
2.43M
EIFDSTour Eiffel DS
0.0184 €
(-57.41%)
110.23k
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
ALMEXMexedia SPA
5.00 €
(-23.08%)
40
ALEUPEuroplasma
0.0413 €
(-14.67%)
3.93M
MLFMVFarminveste
1.20 €
(-14.29%)
1.36k
ATOAtos SE
0.0027 €
(17.39%)
3.02B
ALCYBCybergun
0.0001 €
(-50.00%)
112.66M
NEOENNeoen SA
39.83 €
(0.73%)
81.42M
BCPBanco Comercial Portugues SA
0.4602 €
(2.04%)
75.06M
ALHPIHopium SA
0.005 €
(0.00%)
19.56M

Discusión

Ver feed completo
NinjaOasis53 NinjaOasis53 6 minutos hace
Looking forward to it >> As I said I doubled up between.004-5 but also in at .0015
HLLK
Viking61 Viking61 7 minutos hace
Wasn’t that imbellish that had access to? I can’t remember for sure.
gitreal gitreal 8 minutos hace
If they had invested that $52 million in cash in blue chip stocks, they would now have $60 or 70 million. Tough to invest imaginary money.
AABB
3331 3331 9 minutos hace
Pointing out that Apple has over 15 billion shares - to a bunch of bashers that claim companies with billions of shares are trash (but can't explain why) - is relevant. Twisting it the way you do is not, and demonstrates your complete inability to come up with an intelligent post. I haven't seen a
BIEL
tuzedaze tuzedaze 11 minutos hace
David Fiderer was right about Whalen a long time ago…. https://www.fidererongses.com/blog/params/post/1043010/gse-critics-ignore-credit-market-data
FNMA
jbog jbog 11 minutos hace
We have to keep in mind that Enanta is not following the norm when it comes to small bio research. By far, the majority of bio's of similar size would partner prior to patient trials so they could share the cost and risk. For Enta to develop a drug and then hoping a partner comes along is not good
ddls ddls 12 minutos hace
WOW! BIEL's scammers are out today.😎
BIEL
crazy horse 0 crazy horse 0 13 minutos hace
Did you know this about a wolf pack?

https://x.com/Mindset_Machine/status/1873422311241736563
G-ManSoFla G-ManSoFla 13 minutos hace
A pumper posting another pumper's pump posts? Say that three times fast. By the time you say it will $TNXP be down another 10%?
TNXP
Stinger2014 Stinger2014 13 minutos hace
OC doesn’t answer it just makes noise.
CGAC
theorysuit theorysuit 14 minutos hace
Paid NWBO Retail here gloss over the fact that NWBO paid for LP's CDMOs. That is unreal. It is of no concern, nor do they care....LMFAO at the paid pump crew.
NWBO
TightCoil TightCoil 14 minutos hace
What? Are you getting a raise from
$1.99/hr. to $2.27/hr. for picking up
shopping carts at Krogers.? You deserve it,
Lil Feller
FNMA
th6565 th6565 14 minutos hace
OT : Unless US wins the global battle for semiconductor supremacy, US future economy won’t be smooth sailing on top of high tariffs being proposed.

People in 2025 will be wiped out financially if I keep listening to so many experts’ predictions on the air news.
LWLG
Boris the Spider Boris the Spider 15 minutos hace
LG and LP.

The Perps are so arrogant and delusional that they truly believe that after 16 yrs of wackamole they are untouchable and immune. Here's where they are wrong. If we are not starting to see some payment flow very soon or at least an announcement of forthcoming payouts they c
COOP
Stinger2014 Stinger2014 15 minutos hace
Bingo! Too easy.
CGAC
Acme Investments Acme Investments 15 minutos hace
👇 Why aren't you sailing ⛵ your Yacht in some tropical climate?? Let the shareholders worry about the fate of our ticker!! Big Tony is waiting for the Don to get comfortable and then Boom!!
USEI
worthylion worthylion 16 minutos hace
CCEL Nyberg family filed Form 13G last week showing they have sold all of their 600,000 shares which explains the recent selling pressure and higher volume. Share price now seems poised for a rally leading up to their next .25 dividend at the end of February. 
Doc logic Doc logic 17 minutos hace
Skibum85,

I know that feeling but not from this investment. I have thought about how the reaction will be from those who have gone numb though because it’s folks like you that should be given space on this board to be heard when the celebrations begin and I personally plan to do more
NWBO
prototype_101 prototype_101 19 minutos hace
20 MILLION Shorts Covering Deadline Established June 2025, the gauntlet was put down with the issuance of the new CEO and President Incentive Options being FULLY VESTED in 6 months or June of 2025, this is an UNPRECEDENTED MOVE in the entire history of LWLG!! Normally these types of Incentive Compen
LWLG
52172 52172 20 minutos hace
It will come guaranteed. Patience 2025,6,7 all huge years for amd 
AMD
Hikerbc Hikerbc 20 minutos hace
MULN Stock being attacked by shorters again ? If they roll backup again; then my 7 shares will be zero...............what a disaster this has become.

MULN
meds4life meds4life 21 minutos hace
Nope, not the sitting, but the LYING one
AVXL
52172 52172 22 minutos hace
Coming this week
AMD
Hikerbc Hikerbc 22 minutos hace
Figure Monday we should see an explosive move; hopefully this will spill over to help out AMC ! Share holder of both GME and AMC
AMC GME

Su Consulta Reciente

EU
ACKB
Ackermans and Van Haaren...
BIT
I06733
Intesa Sanpaolo
BIT
UC71MK
Unicredit Bank
BIT
UC8HRS
Unicredit Bank
COIN
PCIGBP
PayProtocol
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados